Thomas Garry J MD - PA Montgomery, Norristown 19401

Thomas Garry J MD entered the industry of Ophthalmologists in 1993 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Ophthalmologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Ophthalmologists. The business provides service to the B2C market.

To acquire more information, please contact Garry Thomas by calling (610) 272-1644 during business hours. You can also write to the business’ Single Location at 2500 Dekalb Pike # 301, Norristown, Pennsylvania PA 19401. You can also visit the company’s website at thomasretinal.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Thomas Garry J MD
Representative: Garry Thomas
Place of Business: 2500 Dekalb Pike # 301, Norristown, PA 19401
Contact Number: (610) 272-1644
Website: thomasretinal.com
Type of Service: Ophthalmologists
SIC Number: 8011
NAICS Number: 6211110
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 1993
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Thomas Garry J MD is a company operating from Montgomery, Pennsylvania providing professional Ophthalmologists and relevant B2C variables. It was founded in 1993 and registered with the SIC code 8011 as Ophthalmologists, and with the NAICS code 6211110 as Ophthalmologists.

With a current employee count of 1 to 4, Thomas Garry J MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Garry Thomas at (610) 272-1644 for related queries, or to locate its Single Location using the coordinates 40.13769,-75.31644.

The Single Location can also be found at the street address 2500 Dekalb Pike # 301 in Norristown, Pennsylvania 19401 and can be engaged online through the company website at thomasretinal.com, the company Twitter , and Facebook page .